LDLR and lung cancer: PSO-HGNPs-DOX demonstrated a good triple therapeutic effectfor lung cancer (A549 cell viability was only 10% at 500 μM) by LDL receptor mediatedendocytosis and was able to escape macrophage phagocytosis to enhance its accumulation atthe target site.